These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21304238)

  • 21. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
    Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
    Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?
    Bonapace ES; Fisher RS; Parkman HP
    Dig Dis Sci; 2000 Jan; 45(1):34-9. PubMed ID: 10695611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Proton Pump Inhibitor Therapy,
    Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
    Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11 months old.
    Treem W; Hu P; Sloan S
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):520-6. PubMed ID: 23689261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours.
    Korse CM; Muller M; Taal BG
    Br J Cancer; 2011 Oct; 105(8):1173-5. PubMed ID: 21989216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does eradication of Helicobacter pylori reduce hypergastrinaemia during long term therapy with proton pump inhibitors?
    Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Polat T
    East Afr Med J; 2003 Mar; 80(3):150-3. PubMed ID: 12762431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
    Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
    Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K; Neumann H; Nocon M; Vieth M; Labenz J; Willich SN; Stolte M; Hocker M; Jaspersen D; Lind T; Malfertheiner P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):491-6. PubMed ID: 18557987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial.
    Helgadóttir H; Metz DC; Lund SH; Gizurarson S; Jacobsen EI; Asgeirsdóttir GA; Yngadóttir Y; Björnsson ES
    J Clin Gastroenterol; 2017 Jul; 51(6):486-493. PubMed ID: 27159420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The risks of long-term proton pump inhibitors use].
    Jiang X; Zhang Q; Zhang Z; Liu Y
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(4):284-8. PubMed ID: 24731496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.
    Cheong JH; Kim GH; Lee BE; Choi MK; Moon JY; Ryu DY; Kim DU; Song GA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):789-96. PubMed ID: 21615222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
    Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.